Zoetis Inc - Class A
Research Zoetis Inc - Class A (ZTS) on Bullrun: market cap USD 32.01B, P/E 12.7, dividend yield 2.8%. Explore financials, valuation history, model signals, and stock context.
Key Metrics
- TickerZTS
- ExchangeNYSE
- CountryUnited States
- SectorHealthcare
- IndustryDrug Manufacturers-Specialty & Generic
- CurrencyUSD
- Market capUSD 32.01B
- P/E12.7
- Dividend yield2.8%
- Financial periodQ2 2026
- RevenueUSD 2.47B
- Net incomeUSD 691.00M
- Free cash flowUSD 538.00M
- Gross margin72.7%
Valuation Snapshot
latest market cap is USD 32.01B; P/E is 12.7; dividend yield is 2.8%.
Peer valuation comparison
Latest P/E is 12.71x versus a Healthcare sector median of 24.46x (48.0% below).
Latest dividend yield is 2.79% versus a Healthcare sector median of 2.11% (32.2% above).
Five-year financial history
| Year | Revenue | Net income | Free cash flow | Gross margin | Diluted EPS | Cash | Total debt | Equity |
|---|---|---|---|---|---|---|---|---|
| FY2025 | USD 9.47B | USD 2.67B | USD 2.28B | 71.8% | 6.02 | USD 2.45B | USD 9.04B | USD 3.42B |
| FY2024 | USD 9.26B | USD 2.49B | USD 2.30B | 70.6% | 5.47 | USD 1.99B | USD 6.57B | USD 4.77B |
| FY2023 | USD 8.54B | USD 2.34B | USD 1.62B | 70.0% | 5.07 | USD 2.04B | USD 6.56B | USD 5.00B |
| FY2022 | USD 8.08B | USD 2.11B | USD 1.33B | 69.6% | 4.49 | USD 3.58B | USD 7.90B | USD 4.41B |
Valuation history
| Year | Snapshot date | Market cap | P/E | Dividend yield | Annual dividend/share |
|---|---|---|---|---|---|
| 2026 | 2026-08-25 | USD 32.01B | 12.7 | 2.7% | 2.09 |
| 2025 | 2025-12-31 | USD 53.46B | 20.9 | 1.6% | 2 |
| 2024 | 2024-12-31 | USD 73.07B | 29.8 | 1.1% | 1.72 |
| 2023 | 2023-12-29 | USD 90.62B | 40.1 | 0.8% | 1.52 |
| 2022 | 2022-12-30 | USD 68.30B | 33.5 | 0.9% | 1.32 |
| 2021 | 2021-12-31 | USD 115.32B | 57.1 | 0.4% | 1 |
Dividend history
Latest trailing dividend snapshot: annual dividend/share 2.09 USD, yield 2.8%.
| Year | Dividends/share |
|---|---|
| FY2025 | 2.03 USD |
| FY2024 | 1.8 USD |
| FY2023 | 1.56 USD |
| FY2022 | 1.35 USD |
About Zoetis Inc - Class A
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep.
Related stock research
Other Healthcare stocks
Frequently asked questions
What is Zoetis Inc - Class A's market cap?
Zoetis Inc - Class A's market capitalization is USD 32.01B.
What is Zoetis Inc - Class A's P/E ratio?
Zoetis Inc - Class A's price-to-earnings (P/E) ratio is 12.7.
Does Zoetis Inc - Class A pay a dividend?
Zoetis Inc - Class A has a dividend yield of 2.8%.
What does Zoetis Inc - Class A do?
Zoetis Inc. engages in the discovery, development, manufacture, and commercialization of medicines, vaccines, diagnostic products and services, biodevices, genetic tests, and precision animal health solutions for the animal health industry in the United States and internationally. The company commercializes products primarily across companion animals comprising dogs, cats, and horses; and species, including livestock, such as cattle, swine, poultry, fish, and sheep.